key: cord-0939094-jj4cectc
authors: Kemlin, Delphine; Lemy, Anne; Pannus, Pieter; Desombere, Isabelle; Gemander, Nicolas; Goossens, Maria E.; Marchant, Arnaud; Le Moine, Alain
title: Hybrid immunity to SARS‐CoV‐2 in kidney transplant recipients and hemodialysis patients
date: 2021-10-01
journal: Am J Transplant
DOI: 10.1111/ajt.16853
sha: 1f2c74165a512d1455abec6a8ab141423ceb4dd3
doc_id: 939094
cord_uid: jj4cectc

A number of studies have emphasised the weak humoral response to COVID-19 m-RNA vaccination in hemodialysis patients and kidney transplant recipients naïve to SARS-CoV-2.1,2 Firket et al.3 recently reported in this journal that kidney transplant recipients previously infected with SARS-CoV-2 develop similar levels of anti-S1/S2 IgG titers compared with healthy controls following of BNT162b2 mRNA vaccination, suggesting that natural infection may prime the immune system for optimal antibody response to COVID-19 mRNA vaccination.

To the Editor:

A number of studies have emphasized the weak humoral response to COVID-19 m-RNA vaccination in hemodialysis patients and kidney transplant recipients naïve to SARS-CoV-2. 1,2 Firket et al. 3 recently reported in this journal that kidney transplant recipients previously infected with SARS-CoV-2 develop similar levels of anti-S1/S2 IgG titers compared with healthy controls following of BNT162b2 mRNA vaccination, suggesting that natural infection may prime the immune system for optimal antibody response to COVID-19 mRNA vaccination.

We would like to report on a larger prospective observational study of the antibody response to the BNT162B2 mRNA vaccine (in- 3 Immunity to SARS-CoV-2 induced by the combination of natural infection and vaccination has been named hybrid immunity in healthy adults. 5 Although the mechanism underlying hybrid immunity remains to be investigated, this process likely depends on the induction of memory B cells and CD4+ T cells by natural infection, leading to up to 100 times higher antibody titers following vaccination. One limitation of our study is that it does not include assessment of cell-mediated immunity. The observation that hybrid immunity can be induced in immunocompromised patients opens an © 2021 The American Society of Transplantation and the American Society of Transplant Surgeons F I G U R E 1 RBD IgG titers (mean and standard error of mean) to BNT162B2 vaccination in hemodialysis patients, kidney transplant recipients, and healthy adult controls naïve or previously infected with SARS-CoV-2. Arrows indicate time of administration of the two vaccine doses. *p < .001 as compared to naïve staff

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Lancet Reg Health Eur

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes. medRxiv

COVID-19 vaccine responses provide insights into how the immune system perceives threats